中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
10期
212-213
,共2页
阿莫西林%左氧氟沙星%消化性溃疡
阿莫西林%左氧氟沙星%消化性潰瘍
아막서림%좌양불사성%소화성궤양
Amoxicil in%Levofloxacin%Peptic ulcer
目的:对左氧氟沙星三联疗法与阿莫西林三联疗法治疗消化性溃疡的疗效进行比较分析。方法将我院收治的56例消化性溃疡患者随机分为研究组和对照组,均为28例,对照组采取阿莫西林三联疗法,研究组采取左氧氟沙星三联疗法,对比两组的临床疗效和用药费用。结果两组的临床治疗总有效率、不良反应发生率差异不具有统计学意义(P>0.05)。研究组的每日用药费用低于对照组。结论对于消化性溃疡的临床治疗,采取左氧氟沙星三联疗法或阿莫西林三联疗法均有良好的临床疗效,不良反应发生率也降低,但前者更经济。
目的:對左氧氟沙星三聯療法與阿莫西林三聯療法治療消化性潰瘍的療效進行比較分析。方法將我院收治的56例消化性潰瘍患者隨機分為研究組和對照組,均為28例,對照組採取阿莫西林三聯療法,研究組採取左氧氟沙星三聯療法,對比兩組的臨床療效和用藥費用。結果兩組的臨床治療總有效率、不良反應髮生率差異不具有統計學意義(P>0.05)。研究組的每日用藥費用低于對照組。結論對于消化性潰瘍的臨床治療,採取左氧氟沙星三聯療法或阿莫西林三聯療法均有良好的臨床療效,不良反應髮生率也降低,但前者更經濟。
목적:대좌양불사성삼련요법여아막서림삼련요법치료소화성궤양적료효진행비교분석。방법장아원수치적56례소화성궤양환자수궤분위연구조화대조조,균위28례,대조조채취아막서림삼련요법,연구조채취좌양불사성삼련요법,대비량조적림상료효화용약비용。결과량조적림상치료총유효솔、불량반응발생솔차이불구유통계학의의(P>0.05)。연구조적매일용약비용저우대조조。결론대우소화성궤양적림상치료,채취좌양불사성삼련요법혹아막서림삼련요법균유량호적림상료효,불량반응발생솔야강저,단전자경경제。
Objective To compare the curative effect of levofloxacin triple therapy and amoxicil in triple therapy for peptic ulcer. Methods 56 patients with peptic ulcer in our hospital were randomly selected into study group and control group,28 cases in each group. The control group patients were treated with amoxicil in triple therapy, while the study group patients were treated with levofloxacin triple therapy. The clinical effect and drug costs of two groups were compared. Results The differences of total effective rate and incidence of adverse reactions between the two groups were not significant(P>0.05). The drug costs of study group was lower than control group. Conclusion The clinical efficacy of Levofloxacin Triple Therapy and Amoxicil in Triple Therapy for the treatment of Peptic Ulcer is good, and the adverse reaction rate is decreased. But the former is more economic, and it is worthy to be promoted in clinic.